TRCT
EXOZ

Tower Research Capital (TRC)’s eXoZymes Inc EXOZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94K Sell
349
-968
-74% -$9.13K ﹤0.01% 4599
2026
Q1 		$9.89K Buy
1,317
+1,315
+65,750% +$12K ﹤0.01% 3908
2025
Q4 		$22 Buy
+2
New +$28 ﹤0.01% 5098
2025
Q3 		– Sell
-344
Closed -$3.4K – 5744
2025
Q2 		$3.4K Sell
344
-789
-70% -$9.62K ﹤0.01% 4500
2025
Q1 		$11.8K Buy
1,133
+744
+191% +$11.1K ﹤0.01% 3497
2024
Q4 		$6.42K Buy
+389
New +$5.74K ﹤0.01% 4172

Other funds holding EXOZ

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Tower Research Capital (TRC)'s EXOZ Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its eXoZymes Inc (EXOZ) stake by 74% in Q2 2026, selling an estimated $9.13K and leaving 349 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #4599.

Tower Research Capital (TRC) first reported a position in EXOZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.8K in Q1 2025. 9 funds tracked by Wall St. Rank hold EXOZ as of Q2 2026.

  • Tower Research Capital (TRC) held 349 shares of eXoZymes Inc worth $2.94K as of Q2 2026.
  • Tower Research Capital (TRC) sold 968 eXoZymes Inc shares in Q2 2026, an estimated $9.13K.
  • eXoZymes Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4599 holding.
  • Tower Research Capital (TRC) first reported a position in eXoZymes Inc in Q4 2024 and has held it in 6 quarters since.
  • Tower Research Capital (TRC)'s eXoZymes Inc position peaked at $11.8K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held eXoZymes Inc as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.